Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Clinical trial NCT04262154 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04262154
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2025-07-07
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.